Revenue

Exodus is using its Bitcoin treasury to buy a payments firm, but declining user metrics and a change in disclosure raise questions about this bold strategy.

With its new CRO from Asana and LinkedIn, HR tech unicorn Lattice is betting on a human-centric AI strategy to dominate the future of performance management.

PathAI's AIM-MASH tool just got dual FDA/EMA approval, a first for AI pathology. This could slash MASH drug development time and reshape clinical trials.

A logistics firm's stock soared 1,100% then collapsed overnight. Inside the alleged pump-and-dump scheme that reveals deep cracks in market integrity.

Beyond a tagline, The Aesthetic Society is expanding to include non-surgeons, a strategic move to set standards and consolidate influence in a booming market.

Ekinops unveils its C700HC chassis, a hybrid system designed to unify telecom offices and data centers, tackling the massive bandwidth demands of AI.

Rivals like OpenAI, Google, and Microsoft are joining forces under the Linux Foundation to build open standards for autonomous AI. What does this mean?

A landmark deal between retail, ad-tech, and media giants aims to build Europe's most advanced data-driven advertising network. What does it mean for brands?

A regulatory filing from Balyasny Asset Management reveals intense investor activity as a bidding war for narcolepsy drugmaker Avadel heats up.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

Cleric's new AI SRE agent promises to end engineering firefighting by learning from incidents. With $9.8M in funding, is this the future of system reliability?

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A new memory module may seem obscure, but it’s a key piece of the puzzle for building trusted AI, resilient 5G, and reliable edge computing.

Regenerative Patch Technologies advances its stem cell therapy for dry AMD, signaling a potential shift from merely slowing blindness to actively improving vision.

A routine UK disclosure by an investment giant has pulled back the curtain on a major transatlantic auto merger and the silent influence of institutional capital.

Hyatt's new safari partnership isn't just a perk; it's a strategic move into purpose-driven travel, redefining luxury loyalty for a new era.

A regulatory filing from Weiss Asset Management reveals a complex arbitrage play on Alphawave IP, spotlighting its critical role in the Qualcomm deal.

A 44% stock implosion and a class-action lawsuit. How Fiserv's broken promises on innovation triggered a crisis and a warning for the FinTech industry.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.